The study, published in Reproductive Sciences, builds on a long line of attempts to model human uterine muscle in the laboratory. Since 1984, when researchers first established methods for growing human myometrial smooth muscle cells in monolayer culture, scientists have wrestled with the limitations of isolated cells. Primary cultures eventually reach replicative senescence, dividing only a finite number of times before they stop. Immortalized lines—created first with viral oncogenes from human papillomavirus type 16 and later with the telomerase enzyme hTERT—can divide indefinitely, but they carry the fingerprints of their engineering: altered cell size, changed expression of smooth muscle actin filaments, and, in some cases, genomic instability. Cell lines derived from pregnant myometrium, such as the PHM1-41 line, retained oxytocin responsiveness and key smooth muscle markers, yet none of these two-dimensional systems preserve the multicellular composition, extracellular matrix, and three-dimensional architecture of intact uterine tissue.

Three-dimensional culture technologies have narrowed that gap. Protein-based gels such as Matrigel and collagen let cells self-organize and remodel their surroundings; bioprinted myometrial rings express contraction markers including alpha-smooth muscle actin, connexin-43, and the oxytocin receptor, and can even contract; polymer scaffolds and microfluidic devices model the uterine wall in increasingly sophisticated ways. But these systems are expensive, slow to prepare, and often demand specialized equipment. Whole-tissue explants—small cubes of biopsied myometrium kept alive in serum-free medium—remain the most faithful stand-in for the real thing. A whole-genome comparison by Georgiou and colleagues found that explants cultured for 30 hours differed from fresh myometrium in only 1,444 genes, whereas primary smooth muscle cells differed in 3,840 and telomerase-immortalized cells in 4,603. Explants, in short, stay closest to the tissue they came from.

Yet even explants are not frozen in time. The Newcastle group had previously shown that during 48 hours of culture, expression of the oxytocin receptor gene OXTR falls while ESR1, PTGS2, PR-A, and AKR1C1 all rise—changes strikingly similar to those documented at the onset of human labor. That observation prompted a bold hypothesis: perhaps non-laboring myometrium does not simply drift in culture but actively transitions toward a labor-like phenotype. If true, the culture dish itself could serve as an ex vivo model of labor onset, allowing researchers to watch the molecular choreography of birth unfold in tissue from a single donor, sampled at baseline and again two days later.

To test the idea, the team collected myometrial biopsies from 30 women undergoing elective cesarean sections at term, between 38.3 and 39.5 weeks of gestation, none of whom were in labor. A small piece of each sample was snap-frozen immediately to capture the true non-laboring baseline. The rest was cut into roughly two-millimeter cubes and incubated for 48 hours in serum-free medium, then frozen for analysis. Using quantitative real-time PCR, the researchers measured the abundance of 30 messenger RNAs spanning contraction-associated proteins, inflammatory mediators, steroid and prostaglandin enzymes, calcium regulators, small heat shock proteins, and phosphodiesterase isoforms. Selected proteins were quantified by Western blotting, with each participant’s fresh tissue serving as the paired control for their own cultured tissue—a design that neatly cancels out individual biological variation.

The results were striking. Genes encoding contraction-associated proteins surged: GJA1, which encodes connexin-43, the gap junction protein that electrically couples uterine muscle cells into a synchronized whole, rose significantly, as did PTGS2, the cyclooxygenase enzyme that drives prostaglandin synthesis, increasing an extraordinary 171-fold on average. ESR1, the estrogen receptor alpha that acts as a master upstream switch for myometrial activation, climbed alongside it. Meanwhile, genes encoding relaxation-associated proteins moved in the opposite direction: PLCL1, a brake on intracellular calcium signaling, dropped at both the mRNA and protein levels, and the small heat shock proteins HSPB1 and HSPB6 also declined. The oxytocin receptor gene OXTR fell to roughly a third of its baseline abundance, echoing findings from laboring tissue in vivo, even though OXTR protein showed only a non-significant downward trend.

The inflammatory arm of the transition was equally dramatic. Nuclear factor kappa B subunits NFκB1 and NFκB3, the cytokines TNFα, IL1β, IL6, and IL8, and the calcium channel TRPV4 all rose significantly, with IL1β increasing 31-fold, IL6 nearly 123-fold, and IL8 more than six-thousand-fold. This sterile inflammatory cascade is a hallmark of labor onset, recruiting immune cells and amplifying prostaglandin production. The team also documented widespread upregulation of phosphodiesterase genes, including all four PDE4 variants and PDE5A, PDE7A, PDE7B, and PDE8A—enzymes that degrade the cyclic nucleotides cAMP and cGMP, which normally keep the pregnant uterus relaxed. Their rise suggests a weakening of the biochemical brakes on contraction, though the roles of most PDE isoforms in human labor remain poorly charted.

Weighing the evidence, the authors found that of 17 targets that could be compared against established in vivo labor-associated changes, 14 shifted in the same direction as genuine labor: ESR1, GJA1, OXTR, PTGS2, PR-A, PR-B, AKR1C1, TNFα, IL1β, IL6, IL8, PLCL1, HSPB1, and HSPB6. Only PTGS1, SRD5A1, and PDE8B behaved in ways that may diverge from the in vivo picture, and these genes are considered secondary players in the labor cascade. AKR1C1, which converts active progesterone into its inactive metabolite 20α-hydroxyprogesterone and thereby enacts a functional progesterone withdrawal, rose in both transcript and protein—consistent with the local progesterone withdrawal thought to unlock the contractile machinery at term.

What drives this transformation in the dish? The authors are careful not to overclaim. Removing tissue from the body abruptly withdraws circulating progesterone and other endocrine signals, cuts off vascular perfusion, alters oxygen and nutrient gradients, and eliminates the mechanical stretch of the gravid uterus, while biopsy and dissection themselves inflict injury that can ignite inflammatory stress. The precise mechanisms remain unresolved, and the study measured only two time points, relied on a targeted gene panel, and did not directly assess tissue viability or contractile function. The researchers acknowledge that future work must map the timeline of the transition with shorter and longer incubations, test whether the molecular shift is accompanied by functional changes in contractility, and validate the model with transcriptome-wide comparisons against genuine laboring tissue.

Even with those caveats, the implications are twofold and significant. On one hand, the findings expose an under-recognized pitfall: experiments that culture supposedly resting myometrial explants for two days or more may no longer be studying the quiescent state they intended to probe, since the tissue has already begun marching toward labor. On the other hand, the reproducible acquisition of labor-associated molecular features offers something genuinely new—an experimentally accessible system in which the transition toward labor can be observed within tissue from the same woman, opening the door to identifying early-response genes, testing candidate triggers and inhibitors, and asking whether the shift toward labor can be slowed, prevented, or reversed. What was once dismissed as culture-induced drift may, it turns out, be a window into the moment life’s most fundamental muscular performance begins.

Subject of Research: An ex vivo model of the molecular transition of term human myometrium toward a labor-like phenotype

Article Title: An Ex Vivo Model for the Onset of Human Labor

Article References: Paul, M., Barreda, A. P., Gregson, A., King, M., Hossain, M. R., Hussein, W. M., Walker, F. R., Smith, R., Zakar, T., & Paul, J. W. (2026). An Ex Vivo Model for the Onset of Human Labor. Reproductive Sciences. https://doi.org/10.1007/s43032-026-02214-4

Image Credits: AI Generated

DOI: 10.1007/s43032-026-02214-4

Keywords: myometrium, labor onset, ex vivo culture, contraction-associated proteins, progesterone withdrawal, inflammation, prostaglandins, oxytocin receptor, preterm birth, reproductive physiology, explants, parturition